Neuraxial Opioids in Obstetrics - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Neuraxial Opioids in Obstetrics

Description:

Distribution and redistribution of ... Specific drugs appropriate for spinal administration. Sites and method of ... Is intermediate hydrophobicity ideal for ... – PowerPoint PPT presentation

Number of Views:1008
Avg rating:5.0/5.0
Slides: 33
Provided by: luya4
Category:

less

Transcript and Presenter's Notes

Title: Neuraxial Opioids in Obstetrics


1
Neuraxial Opioids in Obstetrics
  • Dmitry Portnoy, MD
  • Anesthesiology Department

2
Objectives
  • Description of known mechanisms of spinal
    opioids.
  • Interaction with opioid receptors
  • Distribution and redistribution of spinal opioids
  • Properties that govern pharmacokinetics of spinal
    opioids
  • Clinical application of spinal opioids.
  • Specific drugs appropriate for spinal
    administration
  • Sites and method of administration
  • Recognition and treatment of side effects and
    complications.

3
Historical Perspective
  • 2000 b.c. opium used for pain relief in ancient
    China, Egypt, Rome and Greece.
  • 1899 August Bier injected cocaine to produce
    spinal anesthesia.
  • 1973 Pert and Snyder discovered specific opioid
    receptors of the spinal cord.
  • 1979 Wang et al. reported the first clinical use
    of IT opioids.
  • 1979 Behar et al. - epidural morphine in
    treatment of pain.

4
The Physiology of Pain in Labor
  • Pain during first stage of labor - visceral
  • Dilation of the cervix and distention of the
    lower uterine segment
  • Dull, aching and poorly localized
  • Slow conducting, visceral C fibers, enter spinal
    cord at T10 to L1
  • Can be blocked by spinal opioids alone
  • Pain during second stage of labor somatic
  • Distention of the pelvic floor, vagina and
    perineum
  • Sharp, severe and well localized
  • Rapidly conducting A-delta fibers, enter spinal
    cord at S2 to S4
  • Difficult to block with spinal opioids alone

5
The Physiology of Pain in Labor
6
Mechanism of Action
  • Universal molecular mechanism of opioids
  • Binding to G-protein-coupled opioid receptor
  • Inhibition of adenylate cyclase and voltage-gated
    Ca channels
  • Decrease neuronal excitability, interruption of
    pain transmission
  • Spinal effect the substantia gelatinosa of the
    dorsal horn
  • Highly selective nociceptive pathways
  • Presynaptic receptor action inhibition of
    substance P release
  • Postsynaptic receptor action modulation of pain
    transmission
  • Supraspinal effect inhibition of primary
    afferent transmission in the brainstem, thalamus
    and gray matter

7
Mechanism of Action
8
Mechanism of Action - Bioavailability
  • Effect depends on affinity and ability to reach
    receptors
  • Spinal and epidural opioids - same principle
    mechanism
  • Penetration of neural tissue is the rate limiting
    step
  • Factors affecting transmembrane movements of the
    opioids
  • Molecular weight
  • pK (the lower pK, the greater fraction of
    uncharged form at pH of 7.4)
  • Protein binding
  • Lipid solubility

9
Mechanism of Action Reaching Receptors
  • Epidurally administered drugs must travel
    through
  • dura matter
  • arachnoid matter
  • CSF
  • pia matter
  • white matter
  • gray matter dorsal horn
  • Competing pathways
  • Uptake into epidural epidural fat
  • Uptake into systemic circulation

10
Mechanism of Action Meningeal Permeability
  • Proposed mechanisms of movements spinal drugs
  • Diffusion through spinal meninges
  • Preferential diffusion through spinal nerve root
    cuff
  • Uptake and distribution via radicular blood flow
  • Arachnoid matter is the principle meningeal
    barrier
  • 6-10 layers of tightly adherent cells
  • Repeated aqueouslipid interfaces
  • Contains enzymes that metabolize substances
  • Is intermediate hydrophobicity ideal for spinal
    delivery?

11
(No Transcript)
12
Lipid Solubility and Meningeal Permeability
13
The Fate of Intrathecal Drugs
  • Diffusion into the epidural space systemic
    circulation
  • Diffusion into the spinal
  • cord systemic circulation
  • Rostral spread
  • Bulk movement vs. diffusion
  • Lipid solubility controversy
  • Patient position
  • Baricity

14
The Fate of Intrathecal Drugs
15
Clinical Application of Neuraxial Opioids
  • A medicine would be discovered which should
    suspend sensibility altogether and leave
    irritability or powers of motion unimpaired.
    Benjamine Rush, 1818
  • Any opioid administered anywhere in the body
    will eventually produce analgesia
  • Expectations from neuraxial opioids
    administration
  • Selective enhanced analgesia
  • Reduction in systemic effects and complications
    of opioids
  • Dose-sparing effect (compared to parenteral
    administration)

16
Clinical Application Epidural Opioids Alone
  • No sympathectomy or motor block (except for
    meperidine)
  • Unreliable in advanced labor
  • Hydrophilic drugs Morphine
  • Inconsistent analgesia (50), delayed onset
  • Relatively large dose, increased frequency of
    side effects
  • Increased level in umbilical cord (risk of
    neonatal depression?)
  • Lipophilic drugs Fentanyl, Sufentanil,
    Alfentanil, Meperidine
  • Better analgesia, rapid onset, but short duration
  • Loss of dose-sparing effect, systemic
    absorption

17
Clinical Application Epidural LA and Narcotics
  • Provide both somatic and visceral analgesia.
  • Hasten the onset, effective during 1st and 2nd
    stage of labor.
  • Decrease concentration and total dose of local
    anesthetic
  • Decrease risk of systemic toxicity
  • Decrease risk of high/total spinal
  • Decrease of LA in the fetus
  • Decrease intensity of motor block
  • 2-chloroprocaine mediated inhibition
  • pH dependent (increases fraction of ionized form
    of the drugs)
  • Not pH dependent (impairs mu-receptors activity)

18
Clinical Application Intrathecal Opioids
  • Advantages of intrathecal administration
  • Simple and quick procedure, rapid onset of
    analgesia
  • No motor or sympathetic blockade
  • May be performed by other than anesthesiologist
    physician
  • Limitations of spinal opioids
  • Lack of flexibility for duration and intensity
    of labor
  • Unreliable for advanced labor and instrumental
    delivery
  • Methods to overcome spinal opioids limitations
  • Catheter based techniques (intrathecal or
    combined spinal/epidural)
  • Combination of intrathecal drugs

19
Combine Spinal-Epidural Anesthesia
  • by combining the two methods many of the
    disadvantages of both methods are eliminated and
    their advantages are enhanced to almost
    incredible degree.
  • Soresi AL. Episubdural anesthesia. AA
    193716306-31

20
Combine Spinal-Epidural Anesthesia
  • Advantages of CSE analgesia and anesthesia
  • Rapid onset of intense analgesia
  • Flexibility of epidural blockade as labor
    progress
  • Takes less time and efforts to induce analgesia
  • Possibly more reliable placement of epidural
    catheter
  • Proposed clinical use of CSE technique
  • Early labor ( lt4 cm )
  • Advanced labor ( gt7-8 cm )
  • Second stage

21
Combine Spinal-Epidural AnesthesiaPotential
Problems
  • Spinal puncture
  • Penetration by epidural catheter
  • Leakage of CSF out
  • Leakage of epidural solution in
  • Inability to test epidural catheter
  • Deposition of metallic
  • microparticles
  • Spinal to catheter insertion time, when using
    hyperbaric spinal solutions

22
Maternal Complications and Side effects
  • Classic side effects
  • Respiratory depression
  • Urinary retention
  • Pruritus
  • Nausea and vomiting
  • Rare side effects
  • Mental status changes
  • Hyperalgesia
  • Herpes simplex labialis
  • Ocular dysfunction
  • GI dysfunction
  • Thermoregulation dysfunction
  • Cardiac dysrhythmia
  • Neurotoxicity

23
Maternal Complications and Side
Effectsrespiratory depression
  • Early respiratory depression
  • Lipophilic epidural drugs
  • Develops within 2 hours
  • Likely results from systemic absorption
  • Rostral spread of lipophilic agents also possible
  • Delayed respiratory depression morphine
  • Occurs 6-12 hr, up to 24 hr following
    administration
  • Results from cephalad migration to ventral
    medulla
  • Continues infusion of lipophilic drugs may also
    be implicated

24
Maternal Complications and Side
Effectsrespiratory depression
  • Factors increasing risk of respiratory depression
  • High and repeated doses of opioids
  • Sedatives, co-existing disease
  • lack of opioid tolerance
  • Patient position, increased abdominal and
    intrathoracic pressure
  • Monitoring and management
  • Frequent assessment of somnolence and respiratory
    rate
  • Availability of naloxone at the bedside
  • Standing order and protocol for treatment of
    respiratory depression
  • Availability of a physician who can direct
    resuscitation

25
Maternal complications and side effectspruritus
  • Occurrence - very common, but severe only in 1
  • May be caused by all opioids and dose unrelated
  • Pathogenesis centrally mediated, due to
    cephalad spread
  • Histamine release is probably not involved
  • Concept of an itch center in lower medulla
  • Altered CNS perception of pain
  • Treatment and prophylaxis
  • Diphenhydramine 25mg (most likely secondary to
    sedation)
  • Nalbuphine 5mg, Naloxone 20 40 mcg, naltrexone
    25mg PO
  • Propofol 10 mg (mechanism unknown)
  • Limiting cephalad spread - use of hyperbaric
    spinal solution

26
Addition of Low Concentration Dextrose to
Intrathecal Sufentanil for Labor Analgesia A Way
of Minimizing Pruritus without Affecting Quality
of Analgesia?
overall
gtT6
T6 to L1
ltL1
27
Maternal Complications and Side Effects
  • Nausea and vomiting
  • Difficult to determine opioid mediated incidence
    during labor
  • Probably due to rostral migration to
    chemoreceptor trigger zone
  • More with morphine, dose nondependent
  • Urinary retention
  • Higher incidence with spinal morphine, not
    related to the dose
  • Inhibition of sacral parasympathetic system
    outflow
  • Detrussor muscle relaxation results in increased
    bladder capacity
  • Treatment catheterization, opioid antagonists

28
Maternal Complications and Side Effects
  • Mental status changes, CNS excitation
  • Sedation cephalad spread, dose related
  • Excitation non-opioid receptors interaction
    (basal ganglia)
  • Herpes simplex labialis virus (HSV-1)
    reactivation
  • Trigeminal ganglion trigger (cephalad migration)
  • Skin trigger mechanism secondary to pruritus and
    scratching
  • Gastrointestinal dysfunction
  • Secondary to spinal opioid receptors interaction
  • Delay gastric empting, prolong intestinal transit
    time, dysphagia

29
Maternal Complications and Side Effects
  • Neurotoxicity
  • Not all opioid agents tested for direct effect on
    neural tissue
  • Intrathecal butorphanol may cause neural tissue
    damage
  • Hypotension
  • BP falls by 20 in 14 50 parturients
    following spinal opioid
  • Unlikely secondary to direct sympathectomy effect
  • Abrupt relief of pain, decrease the level of
    adrenaline
  • Opioidergic BP control system?
  • Require the same BP monitoring as a routine
    epidural analgesia

30
Complications and Side EffectsLabor Progress
and Neonatal Morbidity
  • Effect of neuraxial opioids on labor
  • Cause-and-effect relationship is unclear
  • One study showed prolongation of labor with
    spinal morphine
  • Fetal effects
  • Remote possibility of respiratory depression or
    FHR changes
  • Mostly mediated by systemic absorption
  • Small doses of neuraxial opioids appeared to be
    safe
  • Epidural opioids tend to accumulate with time

31
Neuraxial Opioids - Conclusion
  • Effective and safe analgesia with minimal motor
    block
  • For early labor may be used alone
  • For advanced labor - combination with local
    anesthetics
  • Superior postoperative pain control cesarean
    delivery patients
  • Advantageous for high risk patients
  • No sympathectomy, better hemodynamic control
  • Decrease of local anesthetic toxicity
  • Consider limitations and side effects of
    neuraxial opioids
  • Narrow therapeutic ratio for some drugs
  • Limited duration consider catheter based
    techniques
  • Appropriate monitoring is mandatory

32
Case 1
  • 34 y/o male, anesthesiology resident
  • Scheduled for left inguinal hernia repair
  • Medical history unremarkable
  • Allergies PCN, Sulfa
  • Patient requests spinal anesthesia.
  • Intraoperative course
  • SAH with 12.5 mg of 0.75 Bupivacaine 0.2 mg
    Epinephrine 200 mcg of Duramorph. Sensory
    level at T8
  • Sedation with 4 mg of Versed, 100 mcg of Fentanyl
    and incremental Propofol of total 160 mg
  • Fluids 1300 cc of LR, surgical time 45 min
Write a Comment
User Comments (0)
About PowerShow.com